이 페이지를 로드하는 동안 오류가 발생한 것 같습니다.
지원팀에 전달되었습니다. 만약 문제가 지속될 경우 이메일 지원 위젯을 통해 다시 문의 부탁드립니다.
Trend | Peers | Company |
---|---|---|
Is return on equity increasing? | Yes | No |
Is net profit margin increasing? | Yes | No |
Is asset turnover increasing? | Yes | No |
Is equity multiplier increasing? | No | Yes |
Competitors Used |
---|
Aristo Bio-Tech and Lifescience Limited |
Dharmaj Crop Guard Limited |
Heranba Industries Limited |
Narmada Gelatines Limited |
Poddar Pigments Limited |
Return on Equity Benchmarks | ||||||||
Comparable Companies | ||||||||
ARISTO | DHARMAJ | HERANBA | 526,739 | PODDARMENT | CLSL | |||
Return On Equity | ||||||||
Latest Twelve Months | 17% | NA | NA | 15% | NA | 8% | ||
Fiscal Year - 1 | 16% | 13% | 14% | 13% | 9% | 11% | ||
Fiscal Year - 2 | 10% | 41% | 30% | 9% | 8% | 8% | ||
Fiscal Year - 3 | 8% | 46% | 36% | 6% | 11% | 12% | ||
Fiscal Year - 4 | 9% | 47% | 36% | 10% | 10% | 11% | ||
Fiscal Year - 5 | 25% | 63% | 39% | 8% | 8% | NA | ||
Average | 14% | 42% | 31% | 10% | 9% | 10% | ||
Median | 13% | 46% | 36% | 9% | 9% | 11% | ||
Benchmarks | Ticker | |||||||
Aristo Bio-Tech and Lifescience Limited | NSEI:ARISTO | |||||||
Dharmaj Crop Guard Limited | NSEI:DHARMAJ | |||||||
Heranba Industries Limited | NSEI:HERANBA | |||||||
Narmada Gelatines Limited | BSE:526739 | |||||||
Poddar Pigments Limited | NSEI:PODDARMENT |
Financial Performance | ||||||||
Comparable Companies | ||||||||
(in millions) | ARISTO | DHARMAJ | HERANBA | Feb-42 | PODDARMENT | CLSL | ||
Latest Fiscal Year | Mar-24 | Mar-24 | Mar-24 | Mar-24 | Mar-24 | Mar-24 | ||
LTM Period | Sep-24 | Dec-24 | Dec-24 | Sep-24 | Dec-24 | Sep-24 | ||
Revenues | ||||||||
Latest Twelve Months | 3,265 | 8,572 | 13,329 | 1,877 | 3,792 | 2,075 | ||
Fiscal Year | 2,451 | 6,541 | 12,571 | 1,818 | 3,690 | 1,986 | ||
Fiscal Year - 1 | 2,179 | 5,244 | 13,188 | 1,911 | 3,407 | 1,312 | ||
Fiscal Year - 2 | 1,658 | 3,942 | 14,504 | 1,574 | 2,955 | 1,020 | ||
Fiscal Year - 3 | 1,672 | 3,024 | 12,186 | 1,349 | 2,607 | 1,189 | ||
Fiscal Year - 4 | 2,012 | 1,982 | 9,514 | 1,343 | 3,567 | 1,351 | ||
Fiscal Year - 5 | 2,017 | 1,397 | 10,044 | 1,258 | 3,571 | NA | ||
Net Income | ||||||||
Latest Twelve Months | 59 | 339 | 442 | 161 | 264 | 55 | ||
Fiscal Year | 39 | 444 | 349 | 153 | 288 | 60 | ||
Fiscal Year - 1 | 36 | 269 | 1,044 | 153 | 273 | 41 | ||
Fiscal Year - 2 | 14 | 287 | 1,891 | 123 | 213 | 28 | ||
Fiscal Year - 3 | 11 | 210 | 1,542 | 85 | 237 | 37 | ||
Fiscal Year - 4 | 10 | 108 | 977 | 129 | 213 | 32 | ||
Fiscal Year - 5 | 28 | 50 | 754 | 101 | 165 | NA | ||
Total Assets | ||||||||
Latest Fiscal Quarter Prior | 1,284 | NA | NA | 1,190 | NA | 1,806 | ||
Latest Fiscal Quarter | 2,233 | NA | NA | 1,546 | NA | 2,347 | ||
Fiscal Year | 1,273 | 5,633 | 14,796 | 1,336 | 3,885 | 1,725 | ||
Fiscal Year - 1 | 998 | 4,323 | 11,623 | 1,166 | 3,316 | 1,016 | ||
Fiscal Year - 2 | 770 | 2,195 | 10,686 | 1,699 | 3,526 | 946 | ||
Fiscal Year - 3 | 814 | 1,289 | 8,433 | 1,649 | 2,672 | 863 | ||
Fiscal Year - 4 | 879 | 926 | 6,248 | 1,608 | 2,210 | 765 | ||
Fiscal Year - 5 | 906 | 477 | 5,604 | 1,546 | 2,459 | NA | ||
Fiscal Year - 6 | NA | 334 | 4,505 | 1,401 | 2,224 | NA | ||
Common Equity | ||||||||
Latest Fiscal Quarter Prior | 326 | 3,590 | 8,268 | 1,009 | 3,303 | 694 | ||
Latest Fiscal Quarter | 382 | 3,955 | 8,927 | 1,107 | 3,790 | 749 | ||
Fiscal Year | 336 | 3,594 | 8,431 | 1,089 | 3,484 | 717 | ||
Fiscal Year - 1 | 302 | 3,152 | 8,104 | 939 | 2,937 | 406 | ||
Fiscal Year - 2 | 149 | 849 | 7,145 | 1,452 | 3,175 | 360 | ||
Fiscal Year - 3 | 134 | 563 | 5,281 | 1,388 | 2,430 | 331 | ||
Fiscal Year - 4 | 123 | 354 | 3,208 | 1,364 | 1,882 | 297 | ||
Fiscal Year - 5 | 113 | 105 | 2,282 | 1,308 | 2,186 | NA | ||
Fiscal Year - 6 | NA | 55 | 1,573 | 1,238 | 1,972 | NA |